Pyxis Oncology (PYXS) Enterprise Value: 2024-2025
Historic Enterprise Value for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $61.4 million.
- Pyxis Oncology's Enterprise Value fell 14.09% to $61.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$259.9 million, marking a year-over-year decrease of 220.14%. This contributed to the annual value of -$34.2 million for FY2024, which is 111.85% down from last year.
- Per Pyxis Oncology's latest filing, its Enterprise Value stood at $61.4 million for Q3 2025, which was up 395.29% from -$20.8 million recorded in Q2 2025.
- In the past 5 years, Pyxis Oncology's Enterprise Value ranged from a high of $90.6 million in Q1 2024 and a low of -$45.1 million during Q1 2025.
- For the 2-year period, Pyxis Oncology's Enterprise Value averaged around $23.2 million, with its median value being $39.2 million (2024).
- Data for Pyxis Oncology's Enterprise Value shows a maximum YoY tumbled of 153.07% (in 2025) over the last 5 years.
- Quarterly analysis of 2 years shows Pyxis Oncology's Enterprise Value stood at -$34.2 million in 2024, then decreased by 14.09% to $61.4 million in 2025.
- Its last three reported values are $61.4 million in Q3 2025, -$20.8 million for Q2 2025, and -$45.1 million during Q1 2025.